Pay in 4 interest-free payments of $7.45 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Liraglutide is effective at treating both type 2 diabetes and obesity
39 In addition, other promising therapies, including vascular regeneration strategies, extracellular vesicle therapy, and advanced biomaterials, have shown encouraging preclinical potential for patients with myocardial infarction (MI) or advanced HF with reduced ejection fraction (HFrEF) (Fig
Glucagon-like Peptide-1 Receptor Agonists as Add-on Therapy to Insulin for Type 1 Diabetes Mellitus
The performance of different propensity score methods for estimating marginal hazard ratios
US$ 21.64
US$ 25.14
US$ 27.07
